The table below shows BIODESIX INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$23.27M
-$48.65M
-$22.87M
-$44.97M
-$28.22M
-$21.37M
Capital expenditure
$259.00K
$3.23M
$22.92M
$3.30M
$2.24M
$1.95M
Investing cash flow
-$403.00K
-$3.44M
-$23.06M
-$3.53M
-$2.55M
-$2.93M
Dividends paid
-
-
-
-
BDSX operating cash flow (10-K history)
BIODESIX INC reported operating cash flow of -$23.27M for fiscal year 2025. That is up 52.2% from -$48.65M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$21.73M (FY 2019) to -$23.27M. Figures come from the company's audited annual reports as filed with the SEC.